General Information of Drug Transporter (DT)
DT ID DTD0494 Transporter Info
Gene Name SLC9A9
Transporter Name Sodium/hydrogen exchanger 9
Gene ID
285195
UniProt ID
Q8IVB4
Post-Translational Modification of This DT
Overview of SLC9A9 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9A9 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

96

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC9A9 Asparagine 96 has the potential to affect its expression or activity.

Oxidation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9A9 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

580

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC9A9 Cystine 580 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9A9 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

9

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A9 Serine 9 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC9A9 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

149

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A9 Serine 149 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC9A9 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

596

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A9 Serine 596 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC9A9 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

597

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A9 Serine 597 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC9A9 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

600

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A9 Serine 600 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC9A9 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

612

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A9 Serine 612 has the potential to affect its expression or activity.

  Threonine

          8 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9A9 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

463

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A9 Threonine 463 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC9A9 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

464

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A9 Threonine 464 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC9A9 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

465

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A9 Threonine 465 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC9A9 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

472

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A9 Threonine 472 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC9A9 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

480

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A9 Threonine 480 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC9A9 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

481

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A9 Threonine 481 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC9A9 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

485

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A9 Threonine 485 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC9A9 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

615

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A9 Threonine 615 has the potential to affect its expression or activity.

  Tyrosine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9A9 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

591

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A9 Tyrosine 591 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC9A9 [6] , [9]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

622

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A9 Tyrosine 622 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC9A9 [10] , [11]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

631

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A9 Tyrosine 631 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9A9 [12]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

610

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC9A9 Lysine 610 has the potential to affect its expression or activity.
References
1 Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61.
2 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
3 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
4 Phosphoproteins in extracellular vesicles as candidate markers for breast cancer. Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3175-3180.
5 An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62.
6 A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
7 Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
8 Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
9 An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
10 Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition. Blood. 2017 Jan 12;129(2):e1-e12.
11 Sensitive, Robust, and Cost-Effective Approach for Tyrosine Phosphoproteome Analysis. Anal Chem. 2017 Sep 5;89(17):9307-9314.
12 Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.